Featured Articles
-
Is Industry Ready To Take A Bite Out Of Obesity?
7/15/2024
What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?
-
New And Upcoming Trends In Immunodiagnostics
7/15/2024
Explore the latest trends and cutting-edge technologies in immunodiagnostics that are transforming disease detection.
-
CAR T Set The Pace So All Can Win The Cell Therapy Race
7/15/2024
Gain insight into the modest origins of cell therapy manufacturing and how this history has paved the way for future advancements from Bill Shingleton, R&D Leader at Cytiva.
-
Revolutionizing Drug Discovery From "Undruggables" To AI
6/10/2024
Explore four current trends in drug discovery, how each trend addresses some of the most crucial challenges in drug discovery, and the obstacles to their widespread adoption.
-
Revolutionizing Drug Discovery: The Rise Of Fashionable Models
6/6/2024
As a result of advancements in research technology, "fashionable models" such as organoids and organs-on-chips (OoCs) have been developed. Explore organoid and OoC technologies in detail.
-
Nucleic Acid Therapeutics And Environmental Impact
4/11/2024
Nucleic acid therapeutics offer exciting new avenues of treatment. Learn about the history of nucleic acid therapeutics and the environmental impact of manufacturing mRNA and oligonucleotides.
-
Building Biopharma Resilience In Developing Gene Therapies
3/21/2024
Learn about the opportunities and challenges surrounding gene therapies, the importance of collaboration between biopharma startups and academia, difficulties with the talent pipeline, and more.
-
Big Risks Yield Great Rewards In Cell Therapy
2/14/2024
George White, Cytiva’s GM of Product Management for Cell and Gene Therapy, provides insight into the latest developments and strategies in cell therapy and where this dynamic field is headed.
-
Finding The Talent To Fuel Biopharma Breakthroughs
2/13/2024
Explore findings from research into talent pool resilience in the biopharmaceutical industry that incorporate survey insights as well as external data to ensure a more accurate overview.
-
Getting Genomic Medicines Ready For Prime Time
2/5/2024
Explore the benefits of building a manufacturing process early, how research into LNPs in nucleic acid therapeutics will contribute to the development of future drugs, and more.